Literature DB >> 7625512

Women's receptivity to testing for a genetic susceptibility to breast cancer.

H Chaliki1, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley.   

Abstract

Four hundred eighty-four patients undergoing mammography and 498 patients visiting their obstetrician-gynecologist were asked whether they would take a breast cancer 1 (BRCA1) test to detect a genetic susceptibility to breast cancer. More than 90% in both groups said they would take the test. Women were more likely to accept if they were regularly having breast examinations by a physician, believed that mammography effectively detects early breast cancer, and believed that early breast cancer is curable. If shown to have inherited a susceptibility, many reported that they would be very anxious, would want the test repeated, would examine their breasts more often than monthly, and would want mammography more often than yearly. Many also reported that they would recommend testing to relatives.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction; Rochester (New York)

Mesh:

Year:  1995        PMID: 7625512      PMCID: PMC1615827          DOI: 10.2105/ajph.85.8_pt_1.1133

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  13 in total

1.  Inherited breast and ovarian cancer. What are the risks? What are the choices?

Authors:  M C King; S Rowell; S M Love
Journal:  JAMA       Date:  1993-04-21       Impact factor: 56.272

Review 2.  Adherence and psychological adjustment among women at high risk for breast cancer.

Authors:  C Lerman; M Schwartz
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

3.  Linkage of early-onset familial breast cancer to chromosome 17q21.

Authors:  J M Hall; M K Lee; B Newman; J E Morrow; L A Anderson; B Huey; M C King
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

4.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

5.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

6.  Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.

Authors:  L S Friedman; E A Ostermeyer; C I Szabo; P Dowd; E D Lynch; S E Rowell; M C King
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

7.  Genetic counseling for families with inherited susceptibility to breast and ovarian cancer.

Authors:  B B Biesecker; M Boehnke; K Calzone; D S Markel; J E Garber; F S Collins; B L Weber
Journal:  JAMA       Date:  1993-04-21       Impact factor: 56.272

8.  BRCA1 mutations in primary breast and ovarian carcinomas.

Authors:  P A Futreal; Q Liu; D Shattuck-Eidens; C Cochran; K Harshman; S Tavtigian; L M Bennett; A Haugen-Strano; J Swensen; Y Miki
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

9.  Reluctance to undergo predictive testing: the case of Huntington disease.

Authors:  K A Quaid; M Morris
Journal:  Am J Med Genet       Date:  1993-01-01

10.  Report of the International Workshop on Screening for Breast Cancer.

Authors:  S W Fletcher; W Black; R Harris; B K Rimer; S Shapiro
Journal:  J Natl Cancer Inst       Date:  1993-10-20       Impact factor: 13.506

View more
  36 in total

Review 1.  Why should primary care physicians know about breast cancer genetics?

Authors:  L E Pinsky; J B Culver; J Hull; E Levy-Lahad; M Daly; W Burke
Journal:  West J Med       Date:  2001-09

2.  Toward a model informed consent process for BRCA1 testing: a qualitative assessment of women's attitudes.

Authors:  Barbara A Bernhardt; Gail Geller; Misha Strauss; Kathy J Helzlsouer; Michael Stefanek; Patti M Wilcox; Neil A Holtzman
Journal:  J Genet Couns       Date:  1997-06       Impact factor: 2.537

3.  Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.

Authors:  Larissa A Meyer; Meaghan E Anderson; Robin A Lacour; Anuj Suri; Molly S Daniels; Diana L Urbauer; Graciela M Nogueras-Gonzalez; Kathleen M Schmeler; David M Gershenson; Karen H Lu
Journal:  Obstet Gynecol       Date:  2010-05       Impact factor: 7.661

4.  Evaluating the impact of genetic counseling and testing with signal detection methods.

Authors:  Christina G S Palmer; Donald W Hadley
Journal:  J Genet Couns       Date:  2005-02       Impact factor: 2.537

5.  Patient satisfaction of BRCA1/2 genetic testing by women at high risk for breast cancer participating in a prevention trial.

Authors:  Jennifer R Klemp; Anne O'Dea; Carolyn Chamberlain; Carol J Fabian
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

6.  Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.

Authors:  A C DudokdeWit; A Tibben; H J Duivenvoorden; M F Niermeijer; J Passchier
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

7.  Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.

Authors:  Reshma Jagsi; Kent A Griffith; Allison W Kurian; Monica Morrow; Ann S Hamilton; John J Graff; Steven J Katz; Sarah T Hawley
Journal:  J Clin Oncol       Date:  2015-04-06       Impact factor: 44.544

8.  Subjective and Objective Risks of Carrying a BRCA1/2 Mutation in Individuals of Ashkenazi Jewish Descent.

Authors:  Kimberly Kelly; Howard Leventhal; Deborah Toppmeyer; Judy Much; James Dermody; Monica Marvin; Jill Baran; Marvin Schwalb
Journal:  J Genet Couns       Date:  2003-08       Impact factor: 2.537

9.  Cancer genetics service interest in women with a limited family history of breast cancer.

Authors:  Tamara J Somers; Julie C Michael; William M P Klein; Andrew Baum
Journal:  J Genet Couns       Date:  2009-05-14       Impact factor: 2.537

10.  Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers.

Authors:  Anita Caruso; Cristina Vigna; Bruna Marozzo; Fabio M Sega; Isabella Sperduti; Francesco Cognetti; Antonella Savarese
Journal:  J Exp Clin Cancer Res       Date:  2009-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.